News and Announcements
New Listings and Insights On Capital Match’s Borrower Assessment Process
- Published June 22, 2015 11:29AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
The past few weeks have been really exciting here at Capital Match and we pleased to inform you that we have just introduced not one… but two listings on our platform!
Listing #15 – S$100,000 for 6 months at 2.5% interest:
The listing amount is S$100,000 for 6 months at an interest rate of 2.5% per month. The borrower’s core business involves the designing, manufacturing and distribution of corn starch based bioplastic (disposable tableware, bags and packaging). The company was set up in 2008 and is currently the leading producer and supplier of corn starch products in Singapore.
Listing #16 – S$200,000 for 12 months at 2.2% interest:
The listing amount is S$200,000 for 12 months at an interest rate of 2.2% per month. The borrower is a construction company that specializes in steel structures. The company was set up in 2010 by a veteran with 40 years of experience in the industry. NOTE: This company is different from listing #11 which was eventually not accepted by the borrower.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
